Holen Sie sich die Stockscreener-App
1.65
1.23%
0.02
Schlusskurs vom Vortag:
$1.63
Offen:
$1.63
24-Stunden-Volumen:
350.07K
Relative Volume:
0.33
Marktkapitalisierung:
$16.64M
Einnahmen:
$960.60K
Nettoeinkommen (Verlust:
$-7.10M
KGV:
-0.2183
EPS:
-7.56
Netto-Cashflow:
$-8.00M
1W Leistung:
+2.48%
1M Leistung:
+21.32%
6M Leistung:
-10.33%
1J Leistung:
-50.15%
1-Tages-Spanne:
$1.5611
$1.695
1-Wochen-Bereich:
$1.5056
$1.695
52-Wochen-Spanne:
$1.09
$6.2299
Soligenix Inc Stock (SNGX) Company Profile
Firmenname
Soligenix Inc
Sektor
Branche
Telefon
609-538-8200
Adresse
29 EMMONS DRIVE, PRINCETON
Vergleichen Sie SNGX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SNGX
Soligenix Inc
|
1.65 | 16.44M | 960.60K | -7.10M | -8.00M | -7.56 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Soligenix Inc Stock (SNGX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2020-07-28 | Herabstufung | Dawson James | Buy → Neutral |
| 2018-01-31 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2017-08-14 | Bestätigt | Maxim Group | Buy |
| 2017-07-17 | Eingeleitet | H.C. Wainwright | Buy |
Soligenix Inc Aktie (SNGX) Neueste Nachrichten
Soligenix (NASDAQ: SNGX) Featured in NetworkNewsAudio APR on Urgent Need for Rare Disease Therapies - Digital Journal
Soligenix’s HyBryte Therapy Advances as Rare Disease Treatment Gap Grows - citybuzz
NetworkNewsAudio Announces Audio Press Release (APR) on Final Confirmatory Clinical Study Being Done for Treatment of Rare Disease - The Manila Times
Soligenix (NASDAQ: SNGX) Receives Strong Vote of Confidence from Zacks Report Despite Muted Market Response to Clinical Milestone - Digital Journal
Soligenix (NASDAQ: SNGX) Featured in BioMedWire Editorial on Rare Disease Therapies - Digital Journal
Soligenix Featured in Editorial on Growing Need for Rare Disease Therapies - citybuzz
Soligenix Inc. (NASDAQ: SNGX) Advancing Rare-Disease Therapies Positioned at Pivotal Crossroad - GlobeNewswire
Why Soligenix Inc. (DOA0) stock signals breakout potentialInflation Watch & Fast Exit and Entry Strategy Plans - Newser
How Soligenix Inc. (DOA) stock expands through international marketsStop Loss & Weekly High Return Opportunities - Newser
Is Soligenix Inc. (DOA0) stock cheap vs fundamentalsTrade Volume Report & Risk Adjusted Swing Trade Ideas - Newser
Is Soligenix Inc. stock a buy before product launchesWeekly Trend Summary & Expert Verified Stock Movement Alerts - Newser
Breakthrough Therapies Advance as Rare Disease Burden Intensifies Across Aging Populations - GlobeNewswire
Is Soligenix Inc. (DOA) stock in buy zone after pullback2025 Volume Leaders & Low Drawdown Momentum Trade Ideas - Newser
Cutaneous T-cell Lymphoma Market Expected to Experience Major Growth by 2032, According to DelveInsight | Innate Pharma, Galderma R&D, Kyowa Kirin, Citius Pharma, Soligenix, 4SC AG, oligenix, Ligand - Barchart.com
Soligenix’s HyBryte Development Intersects with National Rare Disease Policy Needs - citybuzz
Soligenix (NASDAQ: SNGX) Featured in BioMedWire Editorial Highlighting HyBryte(TM) and Rare Disease Policy - Digital Journal
Soligenix Inc. (NASDAQ: SNGX) Innovative Platform Provides Novel Treatment for Underserved CTCL Space - Yahoo Finance
Will Soligenix Inc. (DOA0) stock gain from lower interest ratesBuy Signal & Fast Entry Momentum Alerts - Newser
Is Soligenix Inc. (DOA0) stock attractive for growth fundsGlobal Markets & Smart Money Movement Tracker - Newser
Is Soligenix Inc. (DOA) stock cheap vs fundamentals2025 Price Targets & Long Hold Capital Preservation Tips - Newser
Why Soligenix Inc. (DOA) stock appears on watchlists2025 EndofYear Setup & Low Risk High Reward Ideas - Newser
Why Soligenix Inc. (DOA) stock attracts HNW investorsQuarterly Profit Summary & Expert Verified Movement Alerts - Newser
Will Soligenix Inc. (DOA) stock maintain strong growthWeekly Trade Review & Daily Profit Maximizing Tips - Newser
Soligenix (NASDAQ: SNGX) Reaches Key Enrollment Milestone in Phase 3 Trial with Encouraging Blinded Response Rate - The Globe and Mail
Soligenix Advances HyBryte Treatment for Rare Disease as Aging Population Faces Growing Healthcare Challenge - citybuzz
Is Soligenix Inc a good long term investmentLow Beta Stocks & Free Superior Stock Performance - earlytimes.in
Is Soligenix Inc. (DOA0) stock safe for risk averse investorsJuly 2025 Summary & Trade Opportunity Analysis Reports - Newser
What downside risks could hit Soligenix Inc. (DOA) stockTrade Exit Report & Community Consensus Picks - Newser
Is Soligenix Inc. (DOA) stock good for long term investing2025 Winners & Losers & Long-Term Growth Stock Strategies - Newser
Soligenix Reaches Enrollment Milestone in Phase 3 CTCL Trial with Promising Early Data - citybuzz
Soligenix (NASDAQ: SNGX) Advancing Heat-Stable Vaccine Platform with New Peer-Reviewed Data - Digital Journal
Is Soligenix Inc DOA a good long term investmentInstitutional Buying Trends & Low Entry Investment Growth - earlytimes.in
Soligenix Announces Synthetic Hypericin Successfully Manufactured at Sterling Pharma Solutions (PR Newswire) - Aktiellt
Soligenix Demonstrates Extended Heat Stability in Filovirus Vaccine Platform - citybuzz
Soligenix Updates United States Medical Advisory Board for Cutaneous T-Cell Lymphoma (PR Newswire) - Aktiellt
Clinical Progress in Rare Disease Signals Long-Term Revenue Potential for Innovators (PR Newswire) - Aktiellt
Take Profit: Is Soligenix Inc. stock cheap at current valuation2025 Dividend Review & Low Risk High Win Rate Picks - moha.gov.vn
Soligenix (NASDAQ: SNGX) Elevates Advisory Network as Rare Disease Strategy Advance - Digital Journal
Soligenix Corporate Update LetterKey Highlights and Upcoming Milestones (PR Newswire) - Aktiellt
Soligenix (NASDAQ: SNGX) Strengthens CTCL Program as DMC Flags No Safety Issues - Digital Journal
Soligenix Appoints Former White House Economist as Strategic Advisor to Advance Rare Disease Treatments - citybuzz
Soligenix Inc. (SNGX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
What insider purchases suggest about Soligenix Inc. (DOA0) stockPortfolio Value Summary & Accurate Intraday Trade Tips - newser.com
Will Soligenix Inc. (DOA) stock see valuation expansionJuly 2025 Momentum & Accurate Technical Buy Alerts - newser.com
Why Soligenix Inc. stock attracts high net worth investorsTrade Entry Summary & Advanced Swing Trade Entry Plans - newser.com
How Soligenix Inc. stock responds to policy changesMarket Trend Review & Accurate Trade Setup Notifications - newser.com
Finanzdaten der Soligenix Inc-Aktie (SNGX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.08%
0.91%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):